Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kastelein, J.
Right arrow Articles by Shepherd, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kastelein, J.
Right arrow Articles by Shepherd, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Introduction

J. Kastelein

Amsterdam, The Netherlands

J. Shepherd

Glasgow, U.K.

References

  1. American Heart Association. 1999 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 1998.
  2. Ose L, Luurila O, Eriksson J, et al. Cerivastatin gender effect: subanalysis of results from a multinational, randomised, double-blind study. Curr Med Res Opin. 2000;16:80–87[CrossRef][Web of Science][Medline]
  3. Insull W, Isaacsohn J, Kwiterovich P, et al. Efficacy and safety of cerivastatin 0·8 mg in patients with hypercholesterolaemia: the pivotal placebo-controlled clinical trial. J Int Med Res. 2000;28:47–68[Web of Science][Medline]
  4. Ma P, Hegele R, Yale HF, Schwartz B. CAVEAT: a randomised, double-blind, parallel group evaluation of cerivastatin 0·4 mg and 0·8 mg compared to atorvastatin 10 mg and 20 mg once daily in patients with combined (type IIb) dyslipidaemia. Br J Cardiol. 2000;7:780–786
  5. Pearson TA, Laurora I, Chu H, Kafonek S. The Lipid Treatment Assessment Project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med. 2000;160:459–467[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Kastelein, J.
Right arrow Articles by Shepherd, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kastelein, J.
Right arrow Articles by Shepherd, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?